BTK-V416L-Recombinant-Human-Active-Protein-Kinase-生命科学试剂-MCE.pdfVIP

  • 0
  • 0
  • 约1.81千字
  • 约 1页
  • 2025-10-15 发布于上海
  • 举报

BTK-V416L-Recombinant-Human-Active-Protein-Kinase-生命科学试剂-MCE.pdf

Hotline:400-820-3792

Inhibitors•ScreeningLibraries•Proteins

www.MedChemE

BTKV416LRecombinantHumanActiveProteinKinase

Cat.No.:HY-E70809

作⽤靶点:Btk

作⽤通路:ProteinTyrosineKinase/RTK

储存⽅式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

⽣物活性布鲁顿酪氨酸激酶(BTK)在B细胞抗原受体(BCR)信号转导通路中起着⾄关重要的作⽤。BTK可⽤于研究淋巴

瘤和⾃⾝免疫性疾病。BTK有多种突变体。BTKV416LRecombinantHumanActiveProteinKinase是⼀种重

组BTKV416L蛋⽩,可⽤于研究BTKV416L相关功能[1]。

REFERENCES

[1].DasD,etal.Next-generationBrutonsTyrosineKinase(BTK)InhibitorsPotentiallyTargetingBTKC481SMutation-Recent

DevelopmentsandPerspectives.CurrTopMedChem.2022;22(20):1674-1691.

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.

Tel:400-820-3792;021Fax:021E-mail:tech@MedChemE

1/1MasterofBioactiveMolecules—您⾝边的抑制剂⼤师

文档评论(0)

1亿VIP精品文档

相关文档